Home Latest News The Crucial Role of the HPV Vaccine in Preventing Cervical Cancer
Latest NewsOncology

The Crucial Role of the HPV Vaccine in Preventing Cervical Cancer

Share
Cancer cervix is the third most common cancer in women worldwide & second most common cancer in India.
Share

A woman recently claimed that there is no need for a cervical cancer vaccine because she believes the HPV virus is imaginary. However, scientific evidence strongly supports the need for the vaccine to protect against cervical cancer.

What is Cervical Cancer?

Cervical cancer is a major health issue worldwide, with about 650,000 new cases each year, resulting in approximately 350,000 deaths. In India, it is the second most common cancer among women, with around 150,000 new cases annually.

The HPV-Cervical Cancer Connection

The link between the Human Papilloma Virus (HPV) and cervical cancer is very strong, even stronger than the link between smoking and lung cancer. A research paper from 1995 showed this strong connection. HPV is a group of more than 30 different viruses that spread through sexual contact and can infect the cervix, vulva, vagina, penis, and anus. Almost all (99.7%) cases of cervical cancer are caused by one or more of these HPV strains, as demonstrated in a 1999 study.

How Does HPV Cause Cancer?

Since HPV is sexually transmitted, most infections occur in sexually active women aged 18-30. Many may get infected without any symptoms, and some might develop warts. Usually, the immune system can clear the virus, but if high-risk strains like HPV 16, 18, 31, and 33 persist, they can lead to cancer. It typically takes 15-20 years from the initial infection for cancer to develop. People with weakened immune systems, such as those with HIV or smokers, have a higher risk of developing cervical cancer.

Early Detection of Cervical Cancer

Because there is a long period between infection and the onset of cancer, screening tests have been used for many years to detect cervical cancer early, even before symptoms appear. The Pap smear test, done every three years, examines cells from the cervix for abnormalities. Advances in testing now allow for the detection of HPV DNA in these samples. A combined Pap smear and HPV DNA test is recommended every five years starting at age 25. This helps identify any early signs of cervical cancer.

Can Cervical Cancer Be Prevented?

Given that almost all cervical cancers are caused by HPV, researchers have developed vaccines to prevent these infections. Two landmark studies in 2007 tested a vaccine targeting four HPV strains: 6 and 11 (which cause warts) and 16 and 18 (which cause cancer). The studies showed that the vaccine provided almost 97-100% protection against early cancerous or precancerous lesions in those not already infected with HPV. However, the effectiveness was only about 40% in the overall population, which included those already infected.

Further analysis showed that the vaccine is more effective when given at a younger age. Therefore, it is recommended to give two doses of the vaccine to girls aged 9-14 before they become sexually active, as this results in a stronger immune response. For those above 15, three doses are required. The HPV vaccine not only reduces the risk of cervical cancer but also anogenital warts and potentially HPV-associated anal cancers. The protection from the vaccine lasts for over ten years, even with a single dose.

Is the HPV Vaccine Safe?

There are concerns about the safety of the HPV vaccine, but extensive research and data from tens of thousands of patients show that it is safe. The vaccine contains virus-like particles but not the viral DNA, meaning it cannot cause an infection. Instead, it tricks the immune system into producing antibodies for protection. Studies have shown no increased risk of infertility, pregnancy complications, or adverse effects on childbearing.

The HPV virus and its association with cervical cancer have been known for over three decades. This knowledge has led to effective screening strategies and the development of vaccines. The HPV vaccine has been available for nearly 20 years and has the potential to significantly reduce the incidence of cervical cancer, which was once the most common cancer among women in India.

The woman who claims the HPV virus is imaginary has not provided credible evidence or detailed information about her own cancer experience. Her statements can mislead people and prevent them from seeking early, potentially life-saving treatment.

The HPV vaccine is a critical tool in the fight against cervical cancer. Scientific evidence overwhelmingly supports its effectiveness and safety. By vaccinating young girls, we can protect them from this serious and potentially deadly disease. It is essential to rely on accurate information and trusted medical advice when making decisions about health and vaccinations.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Air Pollution
Health News

Delhi Chokes Under Toxic Air: Schools Shut, Offices Go Work From Home — How to Stay Safe

New Delhi, 23 December, 2025: Delhi once again finds itself gasping for breath as air pollution levels surge to hazardous levels, pushing authorities...

Colorectal cancer
Latest News

Cervical Cancer Awareness Month 2026: Screening Tips Every Woman Should Know

Cervical cancer is one of the most preventable forms of cancer, yet it remains a leading cause of cancer-related deaths among women globally....

Bird Flu
Latest News

Bird Flu Alert: How to Protect Yourself Without Panicking

Bird flu, also known as avian influenza, is a viral infection primarily affecting birds but capable of infecting humans in rare cases. The...

Latest News

Why Walking 30 Minutes a Day Can Add Years to Your Life

Walking for just 30 minutes a day is one of the simplest yet most effective ways to improve overall health, enhance longevity, and...

Latest News

5 Common Foods That Are Slowly Damaging Your Liver

The liver is one of the most vital organs in the body, responsible for detoxification, metabolizing nutrients, and regulating essential biochemical processes, and...

Section title

Related Articles
Cancer
Latest News

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

Cancer treatment has evolved rapidly over the past few decades, offering patients...

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Latest News

Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity

The Nipah virus is widely regarded as one of the deadliest zoonotic...

Latest News

Stroke Risk in India: Symptoms and Urgent Action Steps

Stroke is a leading cause of death and disability in India, yet...

Oncology

Early Cancer Detection and Testing: How to Overcome Stigma and Misconceptions

Cancer remains one of the most feared diseases worldwide, not only because...

×